We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ALL:NYSEAllstate Corporation (The) analysis

Data as of Oct 14, 2026 - not real-time

Latest price
$236.17
Risk: medium
4/10Medium risk

Summary

The Allstate Corporation trades at $236.17, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Over a rolling month the price has lost 8.4%. With RSI at 49.9 the momentum picture is neutral, alongside a bullish MACD signal. The recent range runs from support at $219.51 up to resistance at $254.83.
On valuation the read is undervalued — earnings multiple of 4.7 versus a 15.5 sector average, below the peer group. The average analyst target implies 14.0% above today's level. Revenue is growing at 11.8% on a 19.0% profit margin. The 1.83% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 25.8%, a beta of -0.42 and a maximum drawdown of 19.4%, position sizing matters here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
The horizons line up on buy — conviction 9 out of 10.

Top market events

  • The Allstate Corporation NYSE:ALL is one of the largest personal property and casualty insurers in the U.
  • Allstate Corp stock closed at USD 242.86 on September 21, 2026, down 2.79 percent. Second-quarter ad
  • Second-quarter revenue hit USD 18.60 billion, up 11.80 percent year over year. Allstate stock costs

Market outlook

Short term

< 1 year

Positive

Model confidence7/107 out of 10

Key factors

  • Trading above the 200-day average of 225.61
  • MACD momentum is positive
  • 30-day price change of -8.4%

Medium term

1–3 years

Positive

Model confidence7/107 out of 10

Key factors

  • P/E of 4.7 versus sector average of 15.5
  • Trading above the 200-day average of 225.61
  • Analyst targets imply +14.0% versus the current price

Long term

> 3 years

Positive

Model confidence9/109 out of 10

Key factors

  • P/E of 4.7 versus sector average of 15.5
  • Analyst targets imply +14.0% versus the current price
  • Profit margin of 19.0% is healthy

Key metrics

Financial health

Revenue Growth11.80%
Profit Margin18.97%
P/E Ratio4.7
ROE46.11%
ROA8.68%
Debt/Equity22.26
P/B Ratio1.9
Op. Cash Flow$12.5B
Free Cash Flow$15.2B
Industry P/E15.5

Technical analysis

TrendNeutral
RSI49.9
Support$219.51
Resistance$254.83
MA 20$230.80
MA 50$247.97
MA 200$225.61
MACDBullish
VolumeDecreasing
Fear & Greed Index91.3

Valuation

Fair Value$1,162.09
Target Price$269.27
Upside/Downside14.02%
GradeUndervalued
TypeBlend
Dividend Yield1.83%

Risk assessment

Beta-0.42
Volatility25.83%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.